Abiopharma

CADRENAL THERAPEUTICS, INC. (CVKD) Announces Executive and Board Changes CADRENAL THERAPEUTICS, INC. (CVKD) announced changes to its leadership team and board of directors. Directors or was appointed. The position includes: Class I, Class III, Audit Committee, Governance Committee, Compensation Committee, Nominating and Corporate Governance Committee. The change is effective as of June 25, 2026. Executive Changes Details:

• Personnel Involved: Directors or, Certain Officers, CFO On, Glynn Wilson
• Actions: Appointed, Elected, Departed
• Committee Assignments: Audit Committee, Governance Committee, Compensation Committee, Nominating and Corporate Governance Committee
• Effective Date: June 25, 2026
• Board Classification: Class I, Class III